Ono Pharmaceutical Co., Ltd.

¥2,352As of Sun 8 Nov 2026, 12:00 UTC
TSE:4528Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 1.27%
Div yield 3.40%
ROE 8.85%
Drug Manufacturers (General)
Beta (5Y) 0.18
PE TTM 14.83
TSR TTM 29.52%
Mkt cap ¥1.106T
ROIC 9.89%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,320
(1.38%)
(59.81%)
Buy 12|0|2|2|7
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
51.26
53.49
56.14
54.53
31.43%
26.26%
25.62%
9.68%
Revenue¥B
70.52
70.05
68.63
69.21
6.37%
4.02%
(0.60%)
(1.35%)
Peers (US$7.022B)
Cap (US$)
PE
28.14B
11.52x
7.533B
15.65x
Capital
TTM
5Y
10Y
Leveragex
1.222
(0.050)
(0.046)
EBIT/Intx
0.550
0.299
0.300
Own earn%
264.18
(24.09)
(26.53)
Sh yield%
35.04
18.63
19.14
Owners
Insiders/Inst%
3.67
49.17
Short interest%
4.39
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
9–14
$1 testx
—
Incr. ROIC%
53